Recombinant new coronavirus vaccine (CHO cell) low-dose group

BIOLOGICAL2 trials

Sponsors

Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.

Conditions

Coronavirus

Phase 1

Phase I Clinical Study of Recombinant Novel Coronavirus Vaccine

Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.Coronavirus

Start: 2020-06-22End: 2021-09-20Updated: 2020-12-03

Phase 2

Clinical Study of Recombinant Novel Coronavirus Vaccine

Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.Coronavirus

Start: 2020-07-12End: 2021-12-15Updated: 2020-12-03

Related Papers

Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials.

2021-03-24353 citations